Reported by Reuters-"The anti-malaria drug quinacrine does not appear to extend the lives of people with the human form of mad cow disease, despite encouraging results from experiments with mice, ...

An early proposal (by Dr Prusiner at UCSF) for a treatment for CJD was the anti-malarial drug quinacrine based on early work in prion-infected cell cultures. We were asked by the Chief Medical Officer ...

Although the reported incidence of these reactions ranges from 0% to 100%, it is important to note that more frequent reactions were observed in early trials that had few patients and primarily used ...

Abstract: We describe a group of experiments designed to set up a reproducible and reliable method for in vivo vacuole staining in Saccharomyces cerevisiae using neutral red, a vital dye previously ...

Detailed morphological evaluation of blood cells became possible, thanks to the famous English scientist, Paul Ehrlich (1854–1915), who in 1877 pioneered the use of chemical dyes as selective ...

In the past 25 years — from 2000 to 2024 — we have witnessed a revolution in the management, treatment, and outcome of what used to be the most lethal hematologic cancer: Philadelphia ...

Toll-like receptors (TLRs) and their signalling pathways have therapeutic potential for the treatment of inflammation, cancer, infection, allergy and autoimmunity. The elucidation of the structure ...

Dr. Freedman, whose expertise is related to diseases involving the mouth, including autoimmune processes, presented a lecture on the effects of lupus and oral health. He began by informing the ...

Heart failure is the final outcome of most cardiovascular diseases and shares risk factors with other cardiovascular pathologies. Among these, inflammation plays a central role in disease progression ...

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy (M.K., G.C.). Department of Cardiovascular Medicine, IRCCS Humanitas Research ...

Correspondence to Dr Antonis Fanouriakis, Rheumatology and Clinical Immunology Unit, “Attikon” University Hospital, Athens 12462, Greece; afanour{at}med.uoa.gr Our objective was to update the EULAR ...

Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria 3052, Australia Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia Sir Peter MacCallum ...